As biological aging progresses, the immune architecture experiences profound functional attenuation known as immunosenescence, marked by thymic involution, diminished naive T-cell repertoires, and systemic subclinical inflammation ("inflammaging"). Modern dietary OEM requirements have evolved past generic multi-vitamins toward multi-mechanistic biotherapeutic solutions that activate quiescent progenitor pathways, clear cellular senescence markers, and modulate systemic homeostasis.
The modern contract manufacturing landscape demands integrated molecular science, strict clinical compliance, and pharmaceutical-grade excipient matching. Leveraging national-level laboratory breakthroughs, SINOFNHealth delivers end-to-end bespoke customization across low-osmotic liquid shots, multi-peptide micro-encapsulations, enzyme powders, and targeted release lipid delivery carriers designed for exceptional bio-availability and proven shelf stability.
The company specializes in four major product lines: foods for special medical purposes (FSMP), special dietary foods, professional sports nutrition products, and staple foods for specific patient groups. Additionally, leveraging proprietary technologies, it develops a diverse range of health and nutritional products, as detailed below:
Covering eight major product categories for the entire population, featuring multiple star products developed using specialized patented technologies:
Included in the national procurement catalog, featuring energy gels, whey protein powder, branched-chain amino acid peptide powder, Joint Guardian, composite vitamin/mineral powder, and glutamine peptide powder, covering all aspects of sports performance—including energy supply, muscle growth, joint protection, and recovery—with zero doping content.
Categorized into complete nutritional formulas, formulations for specific diseases, and component nutritional supplements, with two flagship breakthroughs:
Relying on the scientific research platform of the Chinese Academy of Sciences, the company integrates R&D, production, and sales, focusing on four key sectors: specialized medical nutrition, therapeutic diets, patient staple foods, and sports nutrition. It provides comprehensive solutions including disease-specific nutritional interventions, daily health maintenance, and sports nutrition support.
• General Adults: Weight management, anti-aging beauty care, liver protection during late-night social engagements, endocrine regulation, and uric acid control.
• Female Population: Qi and blood deficiency, menstrual discomfort, ovarian health concerns, and intimate physiological care.
• Child Population: School-aged and preschool children with weakened immunity, picky eating/anorexia, visual fatigue, delayed growth, or poor concentration.
• Middle-Aged & Elderly: Management of hypertension, hyperlipidemia, hyperglycemia; osteoporosis; joint discomfort; memory decline; and cardiac/retinal degeneration.
Entity Profile: Zhongen (Tianjin) Medical Technology Co., Ltd. (SINOFNHealth) is a direct high-tech enterprise under the umbrella of the Chinese Academy of Sciences and the exclusive enterprise within its portfolio dedicated specifically to specialized medical nutrition, FSMP therapeutic diets, and healthy aging nutraceutical solutions.
Manufacturing Scale: Built with a total investment of RMB 350 million, our modern intelligent manufacturing facility spans 80 mu (approx. 5.3 hectares / 13 acres). Housing pharmaceutical-grade cleanrooms, intelligent automated filling lines, and high-precision extraction chambers, the base produces over 100 novel formulations annually, supported by 12 national science and technology milestone projects and extensive published literature.
National Accreditations: Designated official nutrition supplier for the General Administration of Sport of China and direct procurement partner for national Olympic training teams. Multiple formulations serve as designated nutrition products in international sporting competitions.